NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 197 filers reported holding NEVRO CORP in Q4 2019. The put-call ratio across all filers is 0.51 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,877 | -52.1% | 201,700 | -36.6% | 0.01% | -41.7% |
Q2 2023 | $8,089 | -48.2% | 318,200 | -26.3% | 0.01% | -42.9% |
Q1 2023 | $15,613 | +57.8% | 431,900 | +72.8% | 0.02% | +50.0% |
Q4 2022 | $9,896 | -99.3% | 249,900 | +741.4% | 0.01% | +600.0% |
Q3 2022 | $1,384,000 | +110.7% | 29,700 | +98.0% | 0.00% | +100.0% |
Q2 2022 | $657,000 | -89.0% | 15,000 | -81.9% | 0.00% | -85.7% |
Q1 2022 | $5,982,000 | +69.6% | 82,700 | +90.1% | 0.01% | +75.0% |
Q4 2021 | $3,527,000 | -84.6% | 43,500 | -73.5% | 0.00% | -85.7% |
Q1 2021 | $22,878,000 | +1208.8% | 164,000 | +1523.8% | 0.03% | +1300.0% |
Q4 2020 | $1,748,000 | -88.3% | 10,100 | -90.6% | 0.00% | -86.7% |
Q3 2020 | $14,947,000 | -53.2% | 107,300 | -59.9% | 0.02% | -46.4% |
Q2 2020 | $31,946,000 | -18.8% | 267,400 | -32.1% | 0.03% | -26.3% |
Q1 2020 | $39,354,000 | +49.4% | 393,617 | +75.6% | 0.04% | +90.0% |
Q4 2019 | $26,341,000 | +218.9% | 224,100 | +75.9% | 0.02% | +185.7% |
Q2 2019 | $8,259,000 | -34.2% | 127,400 | -36.6% | 0.01% | -36.4% |
Q1 2019 | $12,558,000 | +67.1% | 200,900 | +179.0% | 0.01% | -15.4% |
Q3 2016 | $7,516,000 | +19.2% | 72,000 | -15.8% | 0.01% | +8.3% |
Q2 2016 | $6,306,000 | -1.9% | 85,500 | -28.5% | 0.01% | -20.0% |
Q2 2015 | $6,429,000 | – | 119,600 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tiger Eye Capital LLC | 239,122 | $41,392,000 | 8.25% |
Integral Health Asset Management, LLC | 88,000 | $15,233,000 | 4.53% |
Iron Triangle Partners LP | 168,761 | $29,213,000 | 3.79% |
Eos Focused Equity Management, L.P. | 14,002 | $2,424,000 | 2.37% |
PFM Health Sciences, LP | 311,940 | $53,997,000 | 1.90% |
Perceptive Advisors | 977,565 | $169,217,000 | 1.82% |
Rock Springs Capital Management LP | 395,000 | $68,375,000 | 1.45% |
Lisanti Capital Growth, LLC | 54,302 | $9,400,000 | 1.30% |
HealthCor Management, L.P. | 156,046 | $27,012,000 | 1.04% |
FRED ALGER MANAGEMENT, LLC | 2,136,612 | $369,848,000 | 0.96% |